Back to Search

HIDAYATULLAH MUNSHI, MD

MD

Hematology & Oncology Physician

NPI: 1437258340IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

CMS Specialties

PrimaryMEDICAL ONCOLOGY

Education

HARVARD MEDICAL SCHOOL

Class of 1996

Research & Publications (20)

Reciprocal interactions between adhesion receptor signaling and MMP regulation.
PMID 16680571·Cancer Metastasis Rev·2006
6-review
Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
PMID 15247230·J Biol Chem·2004
8-other
Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells.
PMID 12194986·J Biol Chem·2002
8-other
Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes.
PMID 12138162·J Biol Chem·2002
7-preclinical
Analysis of matrix degradation.
PMID 12070993·Methods Cell Biol·2002
8-other
Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells.
PMID 19681038·J Cell Biochem·2009
7-preclinical
Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
PMID 19509114·Mol Cancer Res·2009
8-other
Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices.
PMID 19458085·J Biol Chem·2009
7-preclinical
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
PMID 18683883·Cancer·2008
8-other
Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
PMID 18544635·J Cell Sci·2008
8-other
Ultrasound of adnexal masses.
PMID 18450134·Semin Ultrasound CT MR·2008
6-review
Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
PMID 18234959·Mol Cancer Res·2008
8-other
Activation-coupled membrane-type 1 matrix metalloproteinase membrane trafficking.
PMID 17650075·Biochem J·2007
7-preclinical
Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines.
PMID 16891464·Mol Cancer Ther·2006
8-other
Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
PMID 16849548·Cancer Res·2006
8-other
Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma.
PMID 15180997·J Biol Chem·2004
8-other
Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase.
PMID 14670950·J Biol Chem·2004
7-preclinical
Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
PMID 12467066·Cancer·2002
8-other
Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report.
PMID 12040287·Am J Clin Oncol·2002
5-case
Chemotherapy in patients with prostate specific antigen-only disease after primary therapy for prostate carcinoma: a phase II trial of oral estramustine and oral etoposide.
PMID 11391599·Cancer·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
675 N SAINT CLAIR ST, 21-100
CHICAGO, IL 60611

Location

Practice Location

675 N SAINT CLAIR ST, CHICAGO, IL
(312) 908-5284

Quick Facts

NPI
1437258340
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
30
Publications
20

Are you this provider?

Claim Your Profile